Exact Mass: 394.1158
Exact Mass Matches: 394.1158
Found 123 metabolites which its exact mass value is equals to given mass value 394.1158
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
9-Bromo-17beta-hydroxy-17-methylandrost-4-ene-3,11-dione
2-(2-Chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione
C471 - Enzyme Inhibitor Setanaxib (GKT137831) is a selective NADPH oxidase (NOX1/4) inhibitor with Kis of 140 and 110 nM, respectively.
2-(7-Chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-yl)-N,N-dimethylacetamide
6-Chloro-5-methyl-1-((2-(2-methylpyrid-3-yloxy)pyrid-5-yl)carbamoyl)indoline
Trifloxystrobin CGA 321113
CONFIDENCE standard compound; INTERNAL_ID 2596
5,4,8-trihydroxy-3,3-dimethoxy-8-chloromethylene-7,9-epoxylignan
SB 242084
Ala Cys Asp Ser
Ala Cys Ser Asp
Ala Asp Cys Ser
Ala Asp Ser Cys
Ala Ser Cys Asp
Ala Ser Asp Cys
Cys Ala Asp Ser
Cys Ala Ser Asp
Cys Asp Ala Ser
Cys Asp Gly Thr
Cys Asp Ser Ala
Cys Asp Thr Gly
Cys Glu Gly Ser
Cys Glu Ser Gly
Cys Gly Asp Thr
Cys Gly Glu Ser
Cys Gly Ser Glu
Cys Gly Thr Asp
Cys Ser Ala Asp
Cys Ser Asp Ala
Cys Ser Glu Gly
Cys Ser Gly Glu
Cys Thr Asp Gly
Cys Thr Gly Asp
Asp Ala Cys Ser
Asp Ala Ser Cys
Asp Cys Ala Ser
Asp Cys Gly Thr
Asp Cys Ser Ala
Asp Cys Thr Gly
Asp Gly Cys Thr
Asp Gly Thr Cys
Asp Ser Ala Cys
Asp Ser Cys Ala
Asp Thr Cys Gly
Asp Thr Gly Cys
Glu Cys Gly Ser
Glu Cys Ser Gly
Glu Gly Cys Ser
Glu Gly Ser Cys
Glu Ser Cys Gly
Glu Ser Gly Cys
Gly Cys Asp Thr
Gly Cys Glu Ser
Gly Cys Ser Glu
Gly Cys Thr Asp
Gly Asp Cys Thr
Gly Asp Thr Cys
Gly Glu Cys Ser
Gly Glu Ser Cys
Gly Ser Cys Glu
Gly Ser Glu Cys
Gly Thr Cys Asp
Gly Thr Asp Cys
Ser Ala Cys Asp
Ser Ala Asp Cys
Ser Cys Ala Asp
Ser Cys Asp Ala
Ser Cys Glu Gly
Ser Cys Gly Glu
Ser Asp Ala Cys
Ser Asp Cys Ala
Ser Glu Cys Gly
Ser Glu Gly Cys
Ser Gly Cys Glu
Ser Gly Glu Cys
Thr Cys Asp Gly
Thr Cys Gly Asp
Thr Asp Cys Gly
Thr Asp Gly Cys
Thr Gly Cys Asp
Thr Gly Asp Cys
Ethyl2-(4-(4-(2-bromo-2-methylpropanoyl)phenyl)cyclohexyl)acetate
3-[ethyl[3-methyl-4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]propiononitrile
[1,1,4,1',4',1'-Quaterphenyl]-4,4-dicarbonaldehyde
1-(1-(2-(4-CHLOROPHENYL)-2-OXOETHYL)PIPERIDIN-4-YL)-2-OXO-2,3-DIHYDRO-1H-BENZO[D]IMIDAZOLE-5-CARBONITRILE
Trifloxystrobin acid
SB-242084
SB 242084 is a selective, competitive and high-affinity (pKi=9.0) 5-HT2C receptor antagonist (crosses the blood-brain barrier). SB 242084 increases basal activity of dopaminergic neurons in the ventral tegmental area (VTA) of the midbrain and dopamine release in the vomeronasal nucleus. SB 242084 also increases mitochondrial gene expression and oxidative metabolism via 5-HT2A receptor. SB 242084 has good research potential in the negative symptoms of anxiety, depression and schizophrenia, as well as in acute organ damage[1][2][3].
6-[(2R,5R)-2-methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one
1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-5-(2-(methylamino)ethyl)-, monohydrochloride
N-{5-acetyl-6-[2-(dimethylamino)vinyl]-2-oxo-2H-pyran-3-yl}-3-(trifluoromethyl)benzenecarboxamide
3-(4-Methoxyphenyl)-3-(4-methylphenyl)sulfonyl-1-phenyl-1-propanone
3-(Benzenesulfonyl)-2-imino-1-propyl-5-dipyrido[1,2-d:3,4-f]pyrimidinone
9-Bromo-17beta-hydroxy-17-methyl-androst-4-ene-3,11-dione
(19S)-19-ethyl-12,19-dihydroxy-8-methoxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione
3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide
3-[[[1,3-Dioxo-2-(2-oxolanylmethyl)-5-isoindolyl]-oxomethyl]amino]benzoic acid
2-[[5-(dimethylsulfamoyl)-1H-indol-3-yl]methylidene]propanedioic acid diethyl ester
N-[3-(2-furanylmethylamino)-2-quinoxalinyl]-3-methylbenzenesulfonamide
5-[4-[(2-Methyl-4-thiazolyl)methylamino]-6-quinazolinyl]-2-furancarboxylic acid ethyl ester
7-benzyl-1,3-dimethyl-8-[(2E)-2-(thiophen-2-ylmethylidene)hydrazinyl]-3,7-dihydro-1H-purine-2,6-dione
(2R)-2-(4-chlorophenyl)-N-[4-(dimethylsulfamoyl)phenyl]-3-methylbutanamide
BNC375
BNC375 is a potent, selective, and orally available type I positive allosteric modulator of α7 nAChRs with an EC50 of 1.9 μM. BNC375 exhibits good CNS-agent like properties and clinical candidate potential. [1].